Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 396,967 | 421,457 | 451,501 | 475,775 | 471,215 |
| Marketable Securities | 389 | 382 | 388 | 139 | 19,872 |
| Receivables | 24,325 | 22,128 | 20,144 | 17,429 | 16,945 |
| Inventories | 986 | 1,054 | 275 | 223 | 231 |
| Other current assets | 16,496 | 14,534 | 15,333 | 15,925 | 16,313 |
| TOTAL | $439,163 | $459,555 | $487,641 | $509,491 | $524,576 |
| Non-Current Assets | |||||
| PPE Net | 12,320 | 9,689 | 10,041 | 8,299 | 7,437 |
| Intangibles | 1,209 | 1,222 | 1,268 | 1,352 | 1,386 |
| Other Non-Current Assets | 52,631 | 41,472 | 1,891 | 657 | 667 |
| TOTAL | $66,160 | $52,383 | $13,200 | $10,308 | $9,490 |
| Total Assets | $505,323 | $511,938 | $500,840 | $519,799 | $534,066 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 5,385 | N/A | 277 | 772 |
| Accounts payable and accrued liabilities | 19,760 | 15,698 | 15,883 | 15,597 | 12,734 |
| Other current liabilities | 9,571 | 5,691 | 9,899 | 9,237 | 8,103 |
| TOTAL | $51,821 | $47,054 | $46,869 | $45,362 | $42,008 |
| Non-Current Liabilities | |||||
| Long Term Debt | 45,710 | 30,263 | 1,018 | 209 | 231 |
| Deferred Revenues | 20,385 | 20,280 | 20,754 | 20,252 | 20,400 |
| Other Non-Current Liabilities | 5,874 | 4,790 | 5,731 | 5,415 | 5,536 |
| TOTAL | $48,394 | $32,577 | $3,699 | $3,116 | $3,285 |
| Total Liabilities | $100,215 | $79,631 | $50,568 | $48,478 | $45,293 |
| Shareholders' Equity | |||||
| Common Shares | 2,766 | 2,765 | 2,765 | 2,765 | 2,764 |
| Retained earnings | -454,869 | -420,512 | -405,321 | -381,909 | -359,278 |
| Other shareholders' equity | 22,381 | 18,772 | 24,303 | 27,111 | 29,925 |
| TOTAL | $405,108 | $432,307 | $450,272 | $471,320 | $488,774 |
| Total Liabilities And Equity | $505,323 | $511,938 | $500,840 | $519,798 | $534,067 |